Clinical Trial

Clinical Study to Assess the Safety and Efficacy of ACV Moringa Effervescent Tablet Intake on Weight Management in Overweight and Class I Obese Study Participants

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 1, 2025 (before its estimated October 24, 2025 completion). Its status may not reflect the trial's current state.
Summary
A Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Single-Centre, Clinical Study to Evaluate the Safety and Efficacy of Intake of ACV Moringa on the Degree of Weight Change in Overweight and Class I Obese Study Participants
Trial Details
NCT Number NCT07098624
Lead Sponsor NovoBliss Research Pvt Ltd
Collaborators: Zywie Ventures Pvt Ltd
Conditions Obese or Overweight Healthy Volunteers
Enrollment 66 participants
Start Date 2025-07-24
Primary Completion 2025-10-24 (estimated)
Study Completion 2025-11-04 (estimated)
Updated on ClinicalTrials.gov 2025-08-01